Hyderabad, April 27:
Pharma major Dr Reddy’s Laboratories Ltd has launched Ezetimibe and Simvastatin tablets in the US market.
The product is a therapeutic equivalent of generic version of Vytorin (Ezetimibe and Simvastatin) tablets, a registered trademark of MSD International GmbH, the Hyderabad-based Dr Reddy’s said in a release issued here on Thursday.
The drug is indicated along with a proper diet to help lower "bad" cholesterol and fats.
The Vytorin brand had US sales of approximately $678 million for the 12 months ended in February 2017, according to IMS Health.
(This article was published on April 27, 2017)
Get more of your favourite news delivered to your inbox
Please enter your email. Thank You.
Newsletter has been successfully subscribed.